Expression of Interest for C-CAMP Netherlands Global Innovation Catapult

Frequently Asked Questions

What kind of funding does this program provide?

The C-CAMP Netherlands Global Innovation Catapult is a market-access and soft-landing program, not a funding program. It does not provide any cash grants, investments, or repayable loans. Its value lies in facilitating market entry, providing regulatory guidance, and offering networking opportunities in the Dutch healthcare ecosystem.

Who is eligible to apply for this program?

Indian health tech companies that have reached a commercial stage (scaling up, revenue generating, or in active deployment/piloting phase) are eligible. Priority is given to technologies that reduce employee workload, enhance operational efficiency, expand care to non-hospital settings, promote patient self-sufficiency, or optimize tasks through automation. Companies with CE certification or a clear pathway to it will receive priority.

What are the key benefits for selected companies?

Selected companies will gain access to expert knowledge and regulatory support for the Dutch healthcare market, participate in a round table service with the Dutch Ministry of Health, Welfare and Sport (VWS), and receive facilitated introductions to key stakeholders in the Dutch healthcare sector by the Netherlands Foreign Investment Agency (NFIA). The program aims to enable partnerships, market validation, and expansion into the Netherlands and the broader EU.

Are travel and accommodation expenses covered?

No, participants are responsible for bearing their own travel and accommodation costs for the visit to the Netherlands. The program focuses on providing market access, knowledge, and networking support.

What is the deadline for applications?

The call for applications closes on July 5th, 2026. Interested companies should submit their Expression of Interest before this date.

What types of health technologies are in focus?

The program seeks technologies that reduce employee workload (e.g., automated vitals, AI diagnostics), enhance operational efficiency (e.g., smart wards, AI assistants), expand care to non-hospital settings (e.g., wearable biosensors, remote monitoring), promote patient self-sufficiency (e.g., portable heart monitoring, at-home rehab), and optimize tasks through automation (e.g., neonatal therapy, medicine dispensaries).

This program is designed to bridge the gap between innovative Indian health tech startups and the thriving Dutch healthcare ecosystem. C-CAMP, in collaboration with the Netherlands Embassy in India and Invest in Holland, has launched the Global Innovation Catapult to serve as a critical entry and expansion pathway for promising Indian companies. The initiative targets health technologies that can significantly benefit Dutch healthcare professionals and patients by addressing key needs such as reducing employee workload, enhancing operational efficiency, expanding care into non-hospital settings like homecare, promoting patient self-sufficiency, and optimizing tasks through automation to limit human intervention. Through this unique catapult program, C-CAMP and its partners aim to foster strategic international collaborations, enable market validation for Indian innovations, and facilitate significant market expansion for selected companies within the Netherlands and the broader European Union. This program is a testament to the commitment of both India and the Netherlands to drive global healthcare innovation through cross-border partnerships, offering a unique opportunity for Indian innovators to gain a foothold in a highly developed European market.

The selection process for the C-CAMP Netherlands Global Innovation Catapult is a rigorous, multi-stage evaluation designed to identify Indian health tech companies with the highest potential for impact and successful integration into the Dutch healthcare ecosystem. Initially, applications submitted via the Expression of Interest (EOI) form will undergo a thorough screening by C-CAMP and its partners, evaluating factors such as technological innovation, alignment with focus areas, commercial maturity (scaling up, revenue-generating, or piloting phase), and regulatory preparedness, with a strong preference for CE certification or a clear pathway to it. A shortlist of promising companies will then be invited for in-person meetings and interactions. During these sessions, a selection committee comprising experts from C-CAMP, the Health Team of the Netherlands Embassy, the Netherlands Foreign Investment Agency (NFIA), and other Dutch healthcare stakeholders will conduct in-depth assessments. The committee will evaluate the company's innovation, its value proposition for the Dutch market, and the team's capacity for international expansion. The final decision will select five companies based on their strategic fit, growth potential, and ability to address critical needs within the Dutch healthcare sector, preparing them for the facilitated market-access visit.

Expression of Interest for C-CAMP Netherlands Global Innovation Catapult

Expression of Interest for C-CAMP Netherlands Global Innovation Catapult

Grant providers

Application Process

How to apply

Sources

Grants closing soon

Competitions closing soon

Equity closing soon

Debt programs

Subsidies

Frequently Asked Questions

Results & next round

About this grant

Eligibility

Timelines & Process

Benefits & Funding

Grants closing soon

Competitions closing soon

Equity closing soon

Debt programs

Subsidies

Startup Software Credits

Higgsfield

Notion

Semrush

Reclaim.ai

Replit

Bolt

Manus

Warp

Mixpanel

Google

Huawei

Microsoft